Build your expertise by refreshing your understanding of the statistics that underpin clinical trials, consistent-with-labeling decisions, consumer use data, and more. Speakers will go over key concepts such as statistical significance, p values, confidence intervals, sample size determination, post hoc subgroup analysis, meta analysis, and noninferiority and superiority trials. This session will run through typical questions and misperceptions about statistics to strengthen your data-driven communications in the FDA-regulated world.


Blake E. Wilson, Counsel, Hogan Lovells LLP
Mark Levenson, Director, Division of Biometrics VII, Office of Biostatistics, CDER, FDA
Moderated by William Garvin, Shareholder, Buchanan Ingersoll & Rooney PC

Additional Presenters to be Announced



  • +$100 for non-members

Webinar & Recording

  • +$100 for non-members
Register Now

Internet Explorer and Microsoft Edge are not supported by the checkout process.

Please use Chrome, Firefox, or Safari.  If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.

An access link will be provided to attendees via email upon registration.

If you are registering on behalf of someone else, the link to access the webinar will go to the email address provided at the point of registration.

Those registering on the day of the webinar will receive an access link via email upon successful payment.

We use Zoom to conduct webinars which works on most devices. You may participate in the webinar on a mobile device via the Zoom App or by dialing in. If you require the dial in information, please contact Coleen Carney at [email protected].

Test your device: https://support.zoom.us/hc/en-us/articles/201362193-Joining-a-meeting

Webinar recordings are sent via email as soon as we are able to process and verify the quality of the recording. This usually occurs within 3 business days of a webinar broadcast.

If multiple people at your organization wish to participate from separate devices, each will be required to purchase access.

Summer Learning Series

The Summer Learning Series brings the top thinkers and leaders of our industry to speak on a broad array of topics essential to the food and drug law professional, covering matters that perhaps we all wish we knew a bit more about as we work and converse with clients, colleagues, and the FDA. Join us this June through July and build foundation in the following subjects: